Pancreatic Cancer Research

ResearcherAlbert Einstein College of MedicineActive in the last 2 years

Jennifer W. Chuy

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0279-7960; OpenAlex author ID A5081297141. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 0, last author 1)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2012: 1 trial · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database. Co-author DOI 10.1093/oncolo/oyaf007↗
  2. Listeria delivers tetanus toxoid protein to pancreatic tumors and induces cancer cell death in mice. Co-author DOI 10.1126/scitranslmed.abc1600↗
  3. Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1177/10732748221134411↗
  4. The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic Cancer. Co-author DOI 10.1007/s12029-019-00316-8↗

Trials 1

  1. Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer Principal investigator NCT01897454↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andreas Kaubisch · 2 shared papers, 2020–2022 · strength 0.25
  2. Sanjay Goel · 2 shared papers, 2020–2022 · strength 0.25
  3. Rachna T. Shroff · 1 shared paper, 2025 · strength 0.20
  4. Matthew Ebia · 1 shared paper, 2025 · strength 0.20
  5. Emanuel F. Petricoin · 1 shared paper, 2025 · strength 0.20
  6. Andrew Eugene Hendifar · 1 shared paper, 2025 · strength 0.20
  7. Raymond Couric Wadlow · 1 shared paper, 2025 · strength 0.20
  8. Lei Zheng · 1 shared paper, 2025 · strength 0.20
  9. Abrahm Levi · 1 shared paper, 2025 · strength 0.20
  10. Jun Gong · 1 shared paper, 2025 · strength 0.20
  11. Arsen Osipov · 1 shared paper, 2025 · strength 0.20
  12. Michael Jon Pishvaian · 1 shared paper, 2025 · strength 0.20
  13. Gillian K. Gresham · 1 shared paper, 2025 · strength 0.20
  14. Lynn McCormick Matrisian · 1 shared paper, 2025 · strength 0.20
  15. Ana Acuña-Villaorduña · 1 shared paper, 2022 · strength 0.15
  16. Michael Shusterman · 1 shared paper, 2020 · strength 0.11
  17. Justin Tang · 1 shared paper, 2020 · strength 0.11
  18. John Christopher McAuliffe · 1 shared paper, 2022 · strength 0.11
  19. Vinod P. Balachandran · 1 shared paper, 2022 · strength 0.11
  20. Dinesh Chandra · 1 shared paper, 2022 · strength 0.11
  21. Benson Chellakkan Selvanesan · 1 shared paper, 2022 · strength 0.11
  22. Wilber Quispe‐Tintaya · 1 shared paper, 2022 · strength 0.11
  23. Claudia Gravekamp · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.